✕
Login
Register
Back to News
HC Wainwright & Co. Assumes AnaptysBio at Buy, Announces Price Target of $95
Benzinga Newsdesk
www.benzinga.com
Neutral 79.4%
Neg 0%
Neu 79.4%
Pos 0%
Comments
No comments yet. Be the first!
Join the discussion
Login to comment
Login to comment